Researchers at University of California, San Diego Moores Cancer Center are evaluating the safety and tolerability of a synthetic cannabinoid called dexanabinol (ETS2101). Delivered as a weekly intravenous infusion, the drug is being tested in patients with all forms of brain cancer, both primary and metastatic.
George Fuller, an astrophysicist and professor of physics who directs UC San Diego’s Center for Astrophysics and Space Sciences, known as CASS, has been selected to receive the 2013 Hans A. Bethe Prize.
Biologists at UC San Diego have unraveled the anti-viral mechanism of a human gene that may explain why some people infected with HIV have much higher amounts of virus in their bloodstreams than others. Their finding could shed light on the mystery of why some people with HIV never develop symptoms of AIDS.
UC San Diego Sulpizio Family Cardiovascular Center has received Modern Healthcare’s highest design honor, the 2012 Modern Healthcare Design Award. Out of more than one hundred entries, only one other project received this honor in 2012.
Five University of California, San Diego graduate students pursuing research at the intersection of bioengineering, medicine and biology are among the 85 recipients of 2013 Siebel Scholars awards, announced by the Siebel Scholars Foundation on September 10, 2012.
The California Institute for Telecommunications and Information Technology (Calit2) at the University of California, San Diego has become the inaugural test site for a new approach to cooling computer servers – a technology that could improve energy efficiency and enable higher-performance computing.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
